Clinical Emergence and Genomic Characterization of Aztreonam–Avibactam-Resistant Escherichia coli ST410 Isolates in China
Antibiotics · 03.08.2026 · 15 (8) · 750
DOI: 10.3390/antibiotics15080750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 03.08.2026. Verfasst von Xiaojie Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Scientific Research Foundation of Guangdong Province, China Health & Medical Development Foundation.
Abstract (Originalsprache)
Background
Aztreonam–avibactam (ATM-AVI) is an important therapeutic option for infections caused by metallo-β-lactamase-producing Enterobacterales. However, the emergence of resistance may limit its clinical effectiveness. Here, we report two high-level ATM-AVI-resistant Escherichia coli isolates recovered from critically ill patients in a tertiary hospital in Guangzhou, both of whom had prior exposure to broad-spectrum antimicrobial agents.
Methods
Antimicrobial susceptibility testing was performed by broth microdilution. Whole-genome sequencing (WGS) was conducted using the Illumina NovaSeq and Oxford Nanopore Technologies platforms for hybrid assembly. Resistome analysis, multilocus sequence typing (MLST), plasmid replicon typing, and phylogenomic analysis were performed. Comparative genomics with global ST410 isolates was used to investigate the evolutionary origin.
Results
Antimicrobial susceptibility testing revealed high-level resistance to ATM-AVI. Hybrid whole-genome sequencing showed that both isolates belonged to the globally disseminated high-risk ST410 lineage and carried blaNDM-5, CTX-M-type extended-spectrum β-lactamase genes, and an identical four-amino-acid insertion in penicillin-binding protein 3 (ftsI_I334IYRIK). Both isolates exhibited highly conserved chromosomal backbones, differed by only 29 core-genome single-nucleotide polymorphisms, and clustered within a China-associated ST410 clade. Notably, their key resistance determinants were located on distinct plasmid backgrounds: blaNDM-5 was found on a predicted conjugative IncFIB/IncFIC plasmid in one isolate and on an IncX1 element with potential mobilization in the other.
Conclusions
These findings provide important clinical evidence of high-level ATM-AVI resistance in Escherichia coli ST410 isolates in China and highlight the emergence of ATM-AVI resistance-associated determinants within a high-risk genomic background. Active phenotypic and genomic surveillance is warranted as ATM-AVI enters broader clinical use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China.
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China.
- Nanning Center for Disease Control and Prevention, Nanning 530023, China.
- National Medical Products Administration Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou 510080, China.
Förderung
- Medical Scientific Research Foundation of Guangdong Province
- China Health & Medical Development Foundation
Zitieren
APA
Li, X., Li, P., Feng, J., Fang, Z., Liu, S., Guo, C., & Hu, B. (2026). Clinical Emergence and Genomic Characterization of Aztreonam–Avibactam-Resistant Escherichia coli ST410 Isolates in China. Antibiotics, 15(8), 750. https://doi.org/10.3390/antibiotics15080750
Vancouver
Li X, Li P, Feng J, Fang Z, Liu S, Guo C, et al. Clinical Emergence and Genomic Characterization of Aztreonam–Avibactam-Resistant Escherichia coli ST410 Isolates in China. Antibiotics. 2026;15(8):750. doi:10.3390/antibiotics15080750
BibTeX
@article{Li2026,
author = {Li, Xiaojie and Li, Pu and Feng, Junchao and Fang, Zhaoyang and Liu, Sheng and Guo, Cheng and Hu, Bo},
title = {Clinical Emergence and Genomic Characterization of Aztreonam–Avibactam-Resistant Escherichia coli ST410 Isolates in China},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {8},
pages = {750},
doi = {10.3390/antibiotics15080750}
}
EUVIMED